Omeros (OMER) Debt to Equity (2010 - 2026)

Omeros' (OMER) quarterly Debt to Equity came in at -$0.83 in Q1 2026, down 82.96% year-on-year from -$4.89 in Q1 2025, and down 47.73% quarter-over-quarter from -$0.56 in Q4 2025.

Omeros (OMER) Debt to Equity (2010 - 2026) Analysis & Trends

Omeros has disclosed Debt to Equity across 17 years of filings, most recently posting -$0.83 for Q1 2026.

  • Debt to Equity for Q1 2026 came in at -$0.83, down 82.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.83 (down 82.96% YoY), and the FY2025 annual result was -$0.56, down 13.71% from the prior year.
  • Debt to Equity came in at -$0.83 for Q1 2026 at Omeros, down from -$0.56 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $15.42 in Q2 2023 to a low of -$63.74 in Q1 2022.
  • The 5-year median for Debt to Equity is -$0.6 (2024), against an average of -$5.53.
  • Across the five-year window, Debt to Equity sank 4431.89% in 2022 and surged 260.4% in 2023, its largest moves.
  • Omeros' Debt to Equity stood at $3.68 in 2022, then sank by 331.87% to -$8.53 in 2023, then jumped by 94.18% to -$0.5 in 2024, then retreated by 13.71% to -$0.56 in 2025, then sank by 47.73% to -$0.83 in 2026.
  • The last three Debt to Equity figures came in at -$0.83 (Q1 2026), -$0.56 (Q4 2025), and -$0.33 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.32
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn -0.83

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.83
Dec 31, 2025 -0.56
Sep 30, 2025 -0.33
Jun 30, 2025 -0.38
Mar 31, 2025 -0.46
Dec 31, 2024 -0.50
Sep 30, 2024 -0.60
Jun 30, 2024 -0.76
Mar 31, 2024 -2.99
Dec 31, 2023 -8.53
Sep 30, 2023 -22.70
Jun 30, 2023 15.42
Mar 31, 2023 5.75
Dec 31, 2022 3.68
Sep 30, 2022 -6.80
Jun 30, 2022 -9.61
Mar 31, 2022 -63.74
Dec 31, 2021 13.18
Sep 30, 2021 -1.19
Jun 30, 2021 -1.27